Atlanta, 30328, GA,
United States
Resilia Pharmaceuticals Technographics
Resilia Pharmaceuticals Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Resilia Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 35 Resilia Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Resilia Pharmaceuticals has purchased the following applications: Microsoft 365 for Collaboration in 2025, WordPress for Web Content Management in 2025, Synergistix CATS Software Suite for Life Sciences CRM in 2023 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Resilia Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Microsoft , Automattic , Synergistix or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Resilia Pharmaceuticals revenues, which have grown to $10.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Resilia Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Resilia Pharmaceuticals Tech Stack and Enterprise Applications
Resilia Pharmaceuticals Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2025 | 2025 |
|
Resilia Pharmaceuticals Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Automattic | Legacy | WordPress | Web Content Management | Content Management | n/a | 2025 | 2025 |
|
Resilia Pharmaceuticals CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Synergistix | Legacy | Synergistix CATS Software Suite | Life Sciences CRM | CRM | n/a | 2023 | 2023 |
In 2023 Resilia Pharmaceuticals provisioned the Synergistix CATS Software Suite for CRM and commercial support in the United States. The Synergistix CATS Software Suite is documented in vendor materials and the Synergistix help area, and it is classified under the Life Sciences CRM category for pharmaceutical commercial operations.
Vendor documentation and the active Resilia C.A.T.S. tenant referenced in Synergistix support materials imply use of core CATS modules, including CATS CRM and CATS Mobile, as the primary interfaces for commercial teams. Implementation aligns with common Life Sciences CRM capabilities, such as account and contact management, call and activity capture for field engagement, sample and inventory tracking, territory alignment, and mobile field data capture to support point of care interactions and reporting.
Deployment is tenant based on the vendor C.A.T.S. platform, indicating a vendor hosted SaaS tenant model that supports Resilia specific configuration and data segregation for U.S. operations. The implementation narrative centers on a cloud delivered application architecture with mobile client support for field users, enabling synchronized field activity and central CRM records.
Operational coverage focuses on commercial operations and field sales support, with the Synergistix help center serving as the documented support channel for the Resilia tenant. Governance appears to be oriented around standard CRM adoption practices, including configuration management, user provisioning for field and commercial staff, and centralized administration by Resilia commercial leadership.
|
|
|
|
|
Tag Management | CRM |
|
2025 | 2025 |
|
Resilia Pharmaceuticals PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Apps Development | PaaS |
|
2025 | 2025 |
|
Resilia Pharmaceuticals IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2022 | 2022 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2025 | 2025 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2024 | 2024 |
|
Resilia Pharmaceuticals CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Security (AppSec) | CyberSecurity |
|
2025 | 2025 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2022 | 2022 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2023 | 2023 |
|
IT Decision Makers and Key Stakeholders at Resilia Pharmaceuticals
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Resilia Pharmaceuticals Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||